CANbridge Pharmaceuticals Inc. (HKG:1228)

Hong Kong · Delayed Price · Currency is HKD

1.990

0.00 (0.00%)

Jul 31, 2026, 4:08 PM HKT

CANbridge Pharmaceuticals Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	49.98	49.98	85.1	102.87	78.97	31.16
Revenue Growth	-20.10%	-41.27%	-17.27%	30.26%	153.43%	158.98%
Gross Profit	37.33	37.33	54.3	64.16	48.89	18.78
Operating Income	-91.93	-91.93	-340.52	-366.55	-457.97	-655.15
Net Income	14.82	14.82	-442.62	-378.84	-483.48	-1,077
Earnings Per Share	0.03	0.03	-1.04	-0.89	-1.14	-11.43
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Chinese Mainland	49.92	49.92	40.97	55.87	31.49	7.35
Other Countries/Regions	0.06	0.06	44.13	47	47.48	23.81
Total	49.98	49.98	85.1	102.87	78.97	31.16

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	66.63	66.63	10.5	137.49	463.11	745.82
Total Debt	16.08	16.08	135.78	141.93	155.28	52.1
Net Cash (Debt)	50.54	50.54	-125.28	-4.44	307.83	693.71
Net Cash Growth	-	-	-	-	-55.63%	-
Net Cash Per Share	0.11	0.11	-0.29	-0.01	0.73	7.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-38.21	-38.21	-122.4	-278.23	-280.98	-587.07
Capital Expenditures	-0.01	-0.01	-0.11	-5.14	-15.2	-5.09
Free Cash Flow	-38.22	-38.22	-122.5	-283.38	-296.18	-592.16
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	74.67%	74.67%	63.81%	62.37%	61.91%	60.26%
Operating Margin	-183.92%	-183.92%	-400.12%	-356.32%	-579.91%	-2102.46%
Pretax Margin	29.65%	29.65%	-520.10%	-368.26%	-612.21%	-3456.26%
Profit Margin	29.65%	29.65%	-520.10%	-368.26%	-612.21%	-3456.26%
FCF Margin	-76.46%	-76.46%	-143.94%	-275.47%	-375.04%	-1900.31%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	59.61	79.35	-	-	-	-
PS Ratio	21.30	23.52	0.62	3.71	11.64	98.48